Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Emgality Generic Name & Formulations
Legal Class
Rx
General Description
Galcanezumab-gnlm 100mg/mL, 120mg/mL; soln for SC inj; preservative-free.
Pharmacological Class
Calcitonin gene-related peptide (CGRP) receptor antagonist.
How Supplied
Single-dose prefilled pen (120mg/mL)—1, 2; Single-dose prefilled syringe—1, 2 (120mg/mL), 3 (100mg/mL)
Manufacturer
Generic Availability
NO
Emgality Indications
Indications
Prophylaxis of migraine. Treatment of episodic cluster headache.
Emgality Dosage and Administration
Adult
Give by SC inj into abdomen, thigh, back of upper arm, or buttocks. Migraine: initially 240mg loading dose (given as 2 consecutive 120mg inj), followed by 120mg monthly. Cluster headache: 300mg (given as 3 consecutive 100mg inj) at the onset of the cluster period, then monthly until the end of the cluster period.
Children
Not established.
Emgality Contraindications
Not Applicable
Emgality Boxed Warnings
Not Applicable
Emgality Warnings/Precautions
Warnings/Precautions
Discontinue if serious or severe hypersensitivity reaction occurs; treat appropriately. Pregnancy. Nursing mothers.
Emgality Pharmacokinetics
See Literature
Emgality Interactions
Not Applicable
Emgality Adverse Reactions
Adverse Reactions
Inj site reactions (eg, pain, erythema, pruritus); hypersensitivity reactions.
Emgality Clinical Trials
See Literature
Emgality Note
Notes
To enroll in the pregnancy exposure registry, call (833) 464-4724 or visit www.migrainepregnancyregistry.com.
Emgality Patient Counseling
See Literature
